MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”)(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common ...

olastrocel is an allogeneic, off-the-shelf cellular therapeutic candidate derived from perinatal tissue and developed under the Company’s AlloStem® platform. It is in clinical development for: ...

Advanced Cell Technology Inc., which has operations in Worcester, put out a statement this morning applauding a California appeals court decision upholding the constitutionality of the state's $3 ...

Losses at Advanced Cell Technology (ACT) of Marlborough deepened in its first quarter, as the cost of clinical trials for its macular degeneration treatments rose, the company said. Advanced Cell ...

MOUNTAIN VIEW, CA / ACCESS Newswire / May 13, 2025 / AbTherx, Inc., a biotechnology company with innovative transgenic technologies that simplify and accelerate antibody discovery, today announced a ...

LIVERMORE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cell and hydrogen technology, is accelerating the ...

Advent is solving stationary electric and thermal power generation demands in remote areas with its Serene methanol-powered hydrogen fuel cell system BOSTON--(BUSINESS WIRE)--Advent Technologies ...

Inc., a biotechnology company pioneering next-generation tissue therapeutics for organ replacement, today announced the completion of its ...

Amplify Cell Technologies, a joint venture between Accelera, Daimler Trucks and PACCAR, recently broke ground at its new battery cell manufacturing plant in Marshall County, Miss. The 500-acre site ...

Advanced Cell Technology Inc. wins $25 million commitment from investment firm Socius Capital Group. Advanced Cell Technology Inc. (OTC:ACTC) secured a $25 million investment to support clinical ...